ProCE Banner Activity

Treatment Selection in HER2-Positive Metastatic Breast Cancer


Download these slides from an expert-led webinar on the latest data for the treatment of HER2-positive metastatic breast cancer.

Released: February 28, 2023

Expiration: February 27, 2024

Begin Activity



Aditya Bardia

Aditya Bardia, MD, MPH

Director, Breast Cancer Research
Associate Professor
Harvard Medical School
Attending Physician
Massachusetts General Hospital
Boston, Massachusetts

Erika P. Hamilton

Erika P. Hamilton, MD

Director, Breast Cancer Research Program
Sarah Cannon Research Institute
Tennessee Oncology
Nashville, Tennessee

Provided by

ProCE Banner


Supported by educational grants from

Puma Biotechnology, Inc.

Seagen Inc.